Paper33733490
Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations.
Ma C and 11 others. Adv Mater, 2021. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations. Papers, record 33733490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33733490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Interleukin 1 Receptor Antagonist Protein | Major topic |
| Animals | |
| Rats | |
| Humans | |
| Nanoparticles | |
| Biological Availability |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020YFA0908900 | National Key R&D Program of China | PubMed | ||
| 2018YFA0902600 | National Key R&D Program of China | PubMed | ||
| GJTD-2018-09 | National Key R&D Program of China | PubMed | ||
| 21877104 | National Natural Science Foundation of China | PubMed | ||
| 21834007 | National Natural Science Foundation of China | PubMed | ||
| 22020102003 | National Natural Science Foundation of China | PubMed |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42921895 | Spatiotemporally Precise Rheumatoid Arthritis Therapy via a Triple-Locked Cascaded Nanoplatform With Dual-Channel Self-Reporting. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42921895 | PubMed |
| 42563363 | Stimuli-Responsive Nanoplatforms for Precision Intervention in Rheumatoid Arthritis. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | https://conductscience.org/library/papers/42563363 | PubMed |
| 42325403 | Nanomedicine Strategies for Rheumatoid Arthritis: Precision Delivery and Immune Microenvironment Modulation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42325403 | PubMed |
| 42253851 | Bio-Inspired and Protein-Based Elastomeric Materials. | Polym Sci Technol | 2026 | https://conductscience.org/library/papers/42253851 | PubMed |
| 41350407 | Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy. | Nat Nanotechnol | 2026 | https://conductscience.org/library/papers/41350407 | PubMed |
| 40727579 | Nanotechnology in Orthopedic Care: Advances in Drug Delivery, Implants, and Biocompatibility Considerations. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40727579 | PubMed |
| 40285644 | Composite Mapping for Peptide-Based Data Storage with Higher Coding Density and Fewer Synthesis Cycles. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40285644 | PubMed |
| 40088037 | Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40088037 | PubMed |
| 39985217 | Biomimetic Nanoplatform for Targeted Rheumatoid Arthritis Therapy: Modulating Macrophage Niches Through Self-Sustaining Positive Feedback-Driven Drug Release Mechanisms. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39985217 | PubMed |
| 38932929 | Highly reliable and efficient encoding systems for hexadecimal polypeptide-based data storage. | Fundam Res | 2023 | https://conductscience.org/library/papers/38932929 | PubMed |
| 37169742 | Applications of synthetic biology in medical and pharmaceutical fields. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37169742 | PubMed |
| 36632509 | Nanomaterial-assisted theranosis of bone diseases. | Bioact Mater | 2023 | https://conductscience.org/library/papers/36632509 | PubMed |
| 36092568 | Long-Lasting Proteinaceous Nanoformulation for Tumor Imaging and Therapy. | ACS Omega | 2022 | https://conductscience.org/library/papers/36092568 | PubMed |
| 35547753 | Mitochondria-targeted supramolecular coordination container encapsulated with exogenous itaconate for synergistic therapy of joint inflammation. | Theranostics | 2022 | https://conductscience.org/library/papers/35547753 | PubMed |
| 35415310 | Dimethylamino group modified polydopamine nanoparticles with positive charges to scavenge cell-free DNA for rheumatoid arthritis therapy. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35415310 | PubMed |
| 35023331 | Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35023331 | PubMed |
| 35018745 | Highly Plasticized Lanthanide Luminescence for Information Storage and Encryption Applications. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35018745 | PubMed |
| 34876139 | Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34876139 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL1RN | 3557 | PubTator's text mining | https://conductscience.org/library/genes/3557 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33733490
GET https://conductscience.org/api/papers/v1/33733490/authors